Abstract
We describe a large-scale chromatographic method to purify alpha 1-antitrypsin (AAT) from human plasma supernatant II + III. Supernatant II + III was injected onto DEAE sepharose CL 6B to get an albumin-rich fraction as well as a fraction that contained about 45% AAT. This intermediate purity AAT fraction was further purified by size-exclusion chromatography on Sephacryl S-200. The product was heated in solution at 60 degrees C for 10 hours in the presence of a stabilizer to lower the risk of transmission of viral diseases. Purity of the AAT concentrate is over 85%; clinical testing of its safety and efficacy in the treatment of PiZ patients is underway.
| Original language | English |
|---|---|
| Pages (from-to) | 31-38 |
| Number of pages | 8 |
| Journal | Developments in Biological Standardization |
| Volume | 67 |
| Publication status | Published - 1987 |
| Externally published | Yes |
ASJC Scopus subject areas
- General Immunology and Microbiology
- Drug Discovery
- Public Health, Environmental and Occupational Health
Fingerprint
Dive into the research topics of 'Large scale chromatographic purification of alpha 1-antitrypsin from human plasma supernatant II + III.'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS